Cargando…
A Novel Immunocompetent Mouse Model for Testing Antifungal Drugs Against Invasive Candida albicans Infection
Disseminated infection by Candida species represents a common, often life-threatening condition. Increased resistance to current antifungal drugs has led to an urgent need to develop new antifungal drugs to treat this pathogen. However, in vivo screening of candidate antifungal compounds requires la...
Autores principales: | Ryan, Lisa K., Hise, Amy G, Hossain, Chowdhury Mobaswar, Ruddick, William, Parveen, Rezwana, Freeman, Katie B., Weaver, Damian G., Narra, Hema P., Scott, Richard W., Diamond, Gill |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712810/ https://www.ncbi.nlm.nih.gov/pubmed/33007818 http://dx.doi.org/10.3390/jof6040197 |
Ejemplares similares
-
Antifungal Potential of Host Defense Peptide Mimetics in a Mouse Model of Disseminated Candidiasis
por: Chowdhury, Mobaswar Hossain, et al.
Publicado: (2018) -
Potent in vitro and in vivo antifungal activity of a small molecule host defense peptide mimic through a membrane-active mechanism
por: Menzel, Lorenzo P., et al.
Publicado: (2017) -
Candida albicans spondylodiscitis in an immunocompetent patient
por: Joshi, Tapan N
Publicado: (2012) -
Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
por: Whaley, Sarah G., et al.
Publicado: (2017) -
Evaluation of the antifungal efficacy of different concentrations of Curcuma longa on Candida albicans: An in vitro study
por: Murugesh, Jeevitha, et al.
Publicado: (2019)